A Single Center Initial Experience with Robotic-Assisted Minimally Invasive Coronary Artery Bypass Surgery (RA-MIDCAB).
coronary artery revascularization
minimally invasive surgery
robotic coronary artery bypass grafting
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
12 Nov 2022
12 Nov 2022
Historique:
received:
27
08
2022
revised:
05
11
2022
accepted:
09
11
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
25
11
2022
Statut:
epublish
Résumé
Minimally invasive procedures have demonstrated their effectiveness in reducing the recovery times while ensuring optimal results and minimizing complications. Regarding the coronary artery surgical revascularization field, the evolution of techniques and technology is permitting new surgical strategies that are increasingly precise and suitable for each patient. We present an initial single center experience with a case series of patients successfully treated with combined robotic harvesting of the left internal mammary artery (LIMA) and minimally invasive direct coronary artery bypass graft (MIDCAB) for the anastomosis. We retrospectively reviewed the records of patients who underwent minimally invasive coronary artery revascularization with the use of two combined techniques at our Institution between January 2021 and October 2022. A total of 17 patients underwent coronary artery bypass grafting with the described approach. The median cardiopulmonary bypass (CPB) and cross-clamp times were 83 min (76-115) and 38 min (32-58), respectively. The median intensive care unit (ICU) and hospital stay were 2 days (1-4) and 8 days (6-11), respectively. The procedure's success was achieved in 100% of patients. The 30-day mortality was 0%. Considering all the limitations related to the small sample, the presented results of a hybrid approach for minimally invasive coronary artery bypass grafting (CABG) appears to be encouraging and acceptable. The main advantage of this approach is related to the reduction of postoperative pain and pulmonary complications.
Sections du résumé
BACKGROUND
BACKGROUND
Minimally invasive procedures have demonstrated their effectiveness in reducing the recovery times while ensuring optimal results and minimizing complications. Regarding the coronary artery surgical revascularization field, the evolution of techniques and technology is permitting new surgical strategies that are increasingly precise and suitable for each patient. We present an initial single center experience with a case series of patients successfully treated with combined robotic harvesting of the left internal mammary artery (LIMA) and minimally invasive direct coronary artery bypass graft (MIDCAB) for the anastomosis.
METHODS
METHODS
We retrospectively reviewed the records of patients who underwent minimally invasive coronary artery revascularization with the use of two combined techniques at our Institution between January 2021 and October 2022.
RESULTS
RESULTS
A total of 17 patients underwent coronary artery bypass grafting with the described approach. The median cardiopulmonary bypass (CPB) and cross-clamp times were 83 min (76-115) and 38 min (32-58), respectively. The median intensive care unit (ICU) and hospital stay were 2 days (1-4) and 8 days (6-11), respectively. The procedure's success was achieved in 100% of patients. The 30-day mortality was 0%.
CONCLUSIONS
CONCLUSIONS
Considering all the limitations related to the small sample, the presented results of a hybrid approach for minimally invasive coronary artery bypass grafting (CABG) appears to be encouraging and acceptable. The main advantage of this approach is related to the reduction of postoperative pain and pulmonary complications.
Identifiants
pubmed: 36422071
pii: jpm12111895
doi: 10.3390/jpm12111895
pmc: PMC9694867
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Thorac Surg. 2006 Sep;82(3):790-4; discussion 794
pubmed: 16928484
Innovations (Phila). 2018 Jul/Aug;13(4):282-286
pubmed: 30130263
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):212-8
pubmed: 22517566
N Engl J Med. 2012 Dec 20;367(25):2375-84
pubmed: 23121323
Rambam Maimonides Med J. 2013 Jul 25;4(3):e0017
pubmed: 23908867
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
Heart Lung Circ. 2020 Jan;29(1):49-61
pubmed: 31253547
Eur J Cardiothorac Surg. 2013 Aug;44(2):288-93; discussion 293-4
pubmed: 23444407
Front Cardiovasc Med. 2022 Aug 30;9:943076
pubmed: 36110419
Eur J Cardiothorac Surg. 2022 Jan 24;61(2):439-446
pubmed: 34392341
Circulation. 2022 Jan 18;145(3):e4-e17
pubmed: 34882436
N Engl J Med. 2012 Apr 19;366(16):1467-76
pubmed: 22452338
J Thorac Cardiovasc Surg. 2014 Jan;147(1):179-85
pubmed: 24172691
J Clin Med. 2021 Nov 21;10(22):
pubmed: 34830720
Ann Thorac Surg. 2008 Dec;86(6):1856-60
pubmed: 19021994
N Engl J Med. 2005 May 26;352(21):2174-83
pubmed: 15917382
Ann R Coll Surg Engl. 2018 Sep;100(Suppl 7):22-33
pubmed: 30179050
Innovations (Phila). 2018 Nov/Dec;13(6):423-427
pubmed: 30540591
Circulation. 2009 Sep 15;120(11 Suppl):S78-84
pubmed: 19752390
N Engl J Med. 2009 Mar 5;360(10):961-72
pubmed: 19228612
J Thorac Cardiovasc Surg. 2011 Oct;142(4):843-9
pubmed: 21388642
Lancet. 2002 Sep 28;360(9338):965-70
pubmed: 12383664